%0 Journal Article
%T Tratamento farmacol¨®gico da gagueira: evid¨ºncias e controv¨¦rsias
%A Vila-Nova
%A Camila
%A Queir¨®s
%A Fernanda
%A Fortaleza
%A Thiago
%A Lucena
%A Rita
%J Jornal Brasileiro de Psiquiatria
%D 2006
%I Universidade Federal do Rio de Janeiro
%R 10.1590/S0047-20852006000300011
%X objective: this article analyzes the pharmacologic treatment of stuttering, assessing the effectiveness of different treatments using psychiatric drugs and further evidences of other drugs in the treatment of this disorder. methods: search in medline database, using the terms stuttering treatment, disfluency, disfluency treatments, botulinum toxin and stuttering treatment, botulinum toxin and disfluency treatment. results: studies involving the following drugs were found: citalopram + clomipramine, desipramine, paroxetine, olanzapine, pimozide, risperidone, tiapride, levetiracetam, divalproex sodium, citalopram + alprazolam, clonidine and bethanecol, as well as clinical trials with the botulinum toxin a and anesthetics. studies with citalopram + clomipramine, paroxetine, olanzapine, citalopram + alprazolam, risperidone, clomipramine and desipramine, levetiracetam, divalproex sodium, lidocaine and botulinum toxin a showed positive results. however, the great majority of pharmacological studies in this area are case series or clinical trials with small samples. conclusion: enough evidences do not exist that justify the use of a specific treatment for stuttering. the presented studies indicate the necessity of accomplishment of more double-blind placebo-controlled trials involving larger samples.
%K stuttering
%K pharmacologic treatment
%K motor disorder
%K dopamine ways.
%U http://www.scielo.br/scielo.php?script=sci_abstract&pid=S0047-20852006000300011&lng=en&nrm=iso&tlng=en